2022 - Research.com Best Scientist Award
2006 - Distinguished Scientist Award, American Heart Association
Philip A. Wolf mainly investigates Internal medicine, Framingham Heart Study, Cardiology, Stroke and Risk factor. In his study, which falls under the umbrella issue of Internal medicine, Body mass index and Confidence interval is strongly linked to Surgery. His Framingham Heart Study study combines topics in areas such as Epidemiology, Gerontology, Cohort study, Blood pressure and Cohort.
His research in Cardiology is mostly concerned with Heart failure. His Stroke research is multidisciplinary, relying on both Incidence, Embolism, Disease, Physical therapy and Angina. His work focuses on many connections between Risk factor and other disciplines, such as Endocrinology, that overlap with his field of interest in Apolipoprotein E.
Philip A. Wolf focuses on Internal medicine, Framingham Heart Study, Stroke, Cardiology and Framingham Risk Score. The various areas that he examines in his Internal medicine study include Endocrinology and Surgery. His Framingham Heart Study study incorporates themes from Dementia, Gerontology, Cohort study and Cohort.
His Stroke research focuses on Hyperintensity and how it connects with White matter. His Cardiology research is multidisciplinary, incorporating elements of Diabetes mellitus and Pathology. As a member of one scientific family, Philip A. Wolf mostly works in the field of Framingham Risk Score, focusing on Common carotid artery and, on occasion, Internal carotid artery.
His primary areas of study are Internal medicine, Framingham Heart Study, Framingham Risk Score, Cardiology and Stroke. Many of his studies on Internal medicine apply to Endocrinology as well. His Framingham Heart Study research is multidisciplinary, incorporating perspectives in Gerontology, Cognition, Dementia, Cohort and Risk factor.
His Framingham Risk Score study combines topics from a wide range of disciplines, such as Offspring, Logistic regression, Cohort study, Common carotid artery and Cognitive decline. His Cardiology study which covers Brain size that intersects with Neuroimaging. In his work, Genetic association is strongly intertwined with Epidemiology, which is a subfield of Stroke.
His scientific interests lie mostly in Internal medicine, Framingham Heart Study, Stroke, Framingham Risk Score and Cardiology. His biological study spans a wide range of topics, including Endocrinology and Single-nucleotide polymorphism. His Framingham Heart Study research incorporates themes from Hyperintensity, Incidence, Effects of sleep deprivation on cognitive performance, Brain-derived neurotrophic factor and Risk factor.
Philip A. Wolf has researched Stroke in several fields, including Physical therapy and Blood pressure. His Framingham Risk Score study incorporates themes from Offspring, Apolipoprotein E, Epidemiology and Cognitive decline. His Cardiology research includes elements of Diabetes mellitus, Fractional anisotropy, Odds ratio and Surgery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.
Philip A. Wolf;Robert D. Abbott;William B. Kannel.
Stroke (1991)
General Cardiovascular Risk Profile for Use in Primary Care The Framingham Heart Study
Ralph B. D’Agostino;Ramachandran S. Vasan;Michael J. Pencina;Philip A. Wolf.
Circulation (2008)
Vascular dementia Diagnostic criteria for research studies: Report of the NINDS‐AIREN International Workshop*
Gustavo C. Roman;T. K. Tatemichi;T. Erkinjuntti;J. L. Cummings.
Neurology (1993)
Impact of Atrial Fibrillation on the Risk of Death The Framingham Heart Study
Emelia J. Benjamin;Philip A. Wolf;Ralph B. D’Agostino;Halit Silbershatz.
Circulation (1998)
Heart Disease and Stroke Statistics—2006 Update A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Thomas Thom;Nancy Haase;Wayne Rosamond.
Circulation (2006)
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Sudha Seshadri;Alexa Beiser;Jacob Selhub;Paul F Jacques.
The New England Journal of Medicine (2002)
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.
Emelia J. Benjamin;Daniel Levy;Sonya M. Vaziri;Ralph B. D'Agostino.
JAMA (1994)
Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation : population-based estimates
W.B Kannel;P.A Wolf;E.J Benjamin;D Levy.
American Journal of Cardiology (1998)
Lifetime risk for development of atrial fibrillation: the Framingham Heart Study.
Donald M. Lloyd-Jones;Thomas J. Wang;Thomas J. Wang;Eric P. Leip;Eric P. Leip;Martin G. Larson;Martin G. Larson.
Circulation (2004)
Probability of stroke: a risk profile from the Framingham Study.
P A Wolf;R B D'Agostino;A J Belanger;W B Kannel.
Stroke (1991)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
The University of Texas Health Science Center at San Antonio
Boston University
Wake Forest University
Boston University
University of California, Davis
Boston University
Boston University
Johns Hopkins University
Boston University
National Institutes of Health
Oregon State University
National Taiwan University
University of Arkansas at Little Rock
KU Leuven
Federal University of Toulouse Midi-Pyrénées
Tufts University
University of Tokyo
University of Pittsburgh
French Research Institute for Exploitation of the Sea
Tohoku Bunka Gakuen University
Aix-Marseille University
University of Luxembourg
Royal College of Surgeons in Ireland
University of Nottingham
University of Helsinki
University of Ontario Institute of Technology